Stay updated on Gantenerumab in Prodromal Alzheimer's: Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now includes a recruitment status update and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a Revision: v3.6.0 note; the previous text items 'Intervention / Treatment' and 'Revision: v3.5.5' were removed.
    Difference
    0.2%
    Check dated 2026-06-12T15:59:16.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5. This represents a minor update to the page version and does not change any study information.
    Difference
    0.0%
    Check dated 2026-06-05T12:57:08.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    No textual changes were detected for the Study Details page; the content remains unchanged. This indicates the page’s information and structure are the same as before.
    Difference
    0.0%
    Check dated 2026-05-29T09:20:05.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    No textual additions or deletions were provided for this study page, indicating no reported updates in the given dataset.
    Difference
    0.0%
    Check dated 2026-05-22T08:11:06.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site version was updated from v3.5.3 to v3.5.4, indicating deployment of updates to the ClinicalTrials.gov interface. The change does not alter the study details or displayed content.
    Difference
    0.0%
    Check dated 2026-05-14T23:14:47.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The Sweden location entry was updated from Malmo, Sweden, 211 46 to Malmö, Sweden, 211 46 to reflect the correct diacritic spelling used for the Malmö site.
    Difference
    0.0%
    Check dated 2026-05-07T20:39:58.000Z thumbnail image

Stay in the know with updates to Gantenerumab in Prodromal Alzheimer's: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.